GO
Loading...

Health Care Equipment and Supplies

More

  • March 27- Alimera Sciences Inc said it has applied a fourth time for U.S. regulatory approval to start selling an eye implant that delivers a drug to treat a form of blindess in diabetes patients. The FDA asked for a new trial of the drug-device combination, but Alimera's partner, Psivida Corp, said that additional trials were not necessary.

  • March 14- Shares of healthcare information provider Castlight Health Inc rose more than 160 percent in their debut, making the listing the strongest by a technology company so far this year. Castlight's shares opened at $37.50 and touched a high of $41.95 on the New York Stock Exchange, valuing the company at about $3.63 billion.

  • March 14- Medical device maker Hologic Inc appointed a former Johnson& Johnson executive as chief operating officer, three months after naming a new chief executive as part of a deal with activist investor Carl Icahn.

  • Venture funds see growth in health care start-ups Sunday, 9 Mar 2014 | 1:17 PM ET

    As healthcare reform begins to take shape, venture capitalists see emerging opportunities in digital health start-ups.

  • March 7- U.S. medical devices maker Biomet Inc filed with U.S. regulators on Friday to raise up to $100 million in an initial public offering of its common shares as its private equity owners look to cash out. The company, which was taken private for $11.4 billion in 2007, said BofA Merrill Lynch, Goldman Sachs and J.P. Morgan were the lead underwriters to the offering.

  • Biomet files for IPO to raise up to $100 mln Friday, 7 Mar 2014 | 6:48 AM ET

    March 7- U.S. medical devices maker Biomet Inc filed with U.S. regulators on Friday to raise up to $100 million in an initial public offering of its common shares. The company, which was taken private for $11.4 billion in 2007 by a private equity consortium, said BofA Merrill Lynch, Goldman Sachs and J.P. Morgan were the lead underwriters to the offering.

  • Feb 28- Shares of medical device maker Endologix Inc fell as much as 28 percent after the company forecast its slowest annual revenue growth in a decade for 2014, hurt by weak sales in the United States.

  • Just ask Bob Costas, who arrived in Sochi to be the main host of NBC's prime time Olympic coverage, and ended up on the sidelines for nearly a week with an eye infection. Heather Holmes, who works for the medical device company Medtronic Inc, regularly puts in more than 100,000 miles a year on long flights to such places as China and India.

  • FRANKFURT, Feb 25- Fresenius Medical Care, which makes kidney dialysis machines, forecast a shock fall in net profit for this year due to healthcare spending cuts in the United States.

  • FRANKFURT, Feb 25- Fresenius Medical Care, which makes kidney dialysis machines, forecast a surprise fall in net profit for this year, in part due to healthcare spending cuts in the United States.

  • Smile! Here's the next 'smart' product Thursday, 20 Feb 2014 | 10:00 AM ET

    P&G is bringing the dentist into your bathroom a smartphone-connected toothbrush, a device that gives personalized advice to help people improve their brushing.

  • Feb 18- Apple Inc is looking at cars and medical devices to diversify its sources of revenue as growth from iPhones and iPads slow, according to a San Francisco Chronicle report.

  • Feb 4- Boston Scientific Corp on Tuesday reported higher-than-expected quarterly results, citing improving demand for its devices that manage irregular heart rhythms. Boston Scientific is also expected to benefit from the introduction of its S-ICD system.

  • Feb 4- Boston Scientific Corp on Tuesday reported higher-than-expected quarterly earnings on higher sales of its implantable devices that manage irregular heart rhythms. Boston Scientific forecast 2014 earnings of 75 cents to 80 cents a share, excluding special items, on revenue of $7.3 billion to $7.5 billion.

  • Boston Scientific earnings up on heart devices Tuesday, 4 Feb 2014 | 7:40 AM ET

    Feb 4- Boston Scientific Corp on Tuesday reported higher fourth-quarter earnings on stronger sales of its implantable devices that manage irregular heart rhythms. The medical device maker said it had earned $108 million, or 8 cents a share, compared with $60 million, or 4 cents a share, a year earlier.

  • Feb 3- U.S. medical device maker Biomet Inc will pay at least $56 million to settle a multi-district lawsuit relating to defective metal hip replacements, a court filing showed, ending a protracted legal tussle. The lawsuits were combined and jointly heard at the federal court of Indiana, the state where Biomet is headquartered.

  • Feb 3- Medical device maker Hologic Inc reported a better-than-expected adjusted quarterly profit as it sold more 3 D systems that help detect breast cancer, and its CEO said he would pursue the strategic review started by his predecessor.

  • Feb 3- Medical device maker Hologic Inc reported a better-than-expected adjusted quarterly profit in part due to higher sales of its 3 D digital mammography systems. Hologic shares rose 4 percent in extended trading.

  • Feb 3- Medical device maker Hologic Inc reported a better-than-expected adjusted quarterly profit, helped by higher sales of its 3 D digital mammography systems. Hologic shares rose 4 percent in extended trading. Excluding items, Hologic earned 34 cents per share, ahead of analysts' average estimate of 31 cents per share, according to Thomson Reuters I/B/E/S.

  • Jan 17- Medtronic Inc's minimally invasive system for replacing diseased heart valves won U.S. approval for use in patients deemed too frail to endure traditional open heart surgery, the U.S. medical device maker said on Friday.

Most Popular Video

Tuesday, 15 Apr 2014 | 6:00 PM ET

Fear and loathing. Mad Money host Jim Cramer looks at fears professional money managers face in the current market environment.

Tuesday, 15 Apr 2014 | 4:00 PM ET

CNBC's Patti Domm sits down with Lindsey Group Chief Market Analyst Peter Boockvar to discuss whether or not inflation could affect the Fed's plans.

Tuesday, 15 Apr 2014 | 3:00 PM ET

CNBC.com Senior Writer John Jannarone talks about what Coca-Cola really needs to do to sustain revenue growth.